Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone accrual. Canonical Wnt/β-catenin signalling is also known to be activated in mechanotransduction. Sclerostin neutralizing antibodies are being tested in ongoing clinical trials to target osteoporosis and osteogenesis imperfecta but their interaction with mechanical stimuli on bone formation remains unclear. <i>Sost</i> knockout (KO) mice were examined to gain insight on how long-term <i>Sost</i> deficiency alters the local mechanical environment within the bone. This knowledge is crucial since the strain environment regulates bone adaptation. We characterized the bone geometry at the tibial midshaft of young and adult <i>Sost</i> KO and age-...
AbstractMechanical loading is the primary functional determinant of bone mass and architecture, and ...
Osteogenesis imperfecta (OI) is a rare bone disease that is associated with fractures and low bone m...
Mechanical loading is the primary functional determinant of bone mass and architecture, and osteocyt...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the Sost gene, is a Wnt-inhibitor and thus negatively regulates bone accrua...
Loss-of-function mutations in the Sost gene lead to high bone mass phenotypes. Pharmacological inhib...
Bone adaptation optimizes mass and structure, but the mechano-response is already reduced at matura...
Bone adaptation optimizes mass and structure, but the mechano-response is already reduced at maturat...
A new therapeutic option to treat osteoporosis is focused on Wnt signaling and its inhibitor scleros...
Sclerostin, encoded by the Sost gene, is an important negative regulator of bone formation that has ...
Sclerostin, the Wnt signaling antagonist encoded by the Sost gene, is secreted by osteocytes and inh...
SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone fo...
AbstractMechanical loading is the primary functional determinant of bone mass and architecture, and ...
Osteogenesis imperfecta (OI) is a rare bone disease that is associated with fractures and low bone m...
Mechanical loading is the primary functional determinant of bone mass and architecture, and osteocyt...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the <i>Sost</i> gene, is a Wnt-inhibitor and thus negatively regulates bone...
Sclerostin, a product of the Sost gene, is a Wnt-inhibitor and thus negatively regulates bone accrua...
Loss-of-function mutations in the Sost gene lead to high bone mass phenotypes. Pharmacological inhib...
Bone adaptation optimizes mass and structure, but the mechano-response is already reduced at matura...
Bone adaptation optimizes mass and structure, but the mechano-response is already reduced at maturat...
A new therapeutic option to treat osteoporosis is focused on Wnt signaling and its inhibitor scleros...
Sclerostin, encoded by the Sost gene, is an important negative regulator of bone formation that has ...
Sclerostin, the Wnt signaling antagonist encoded by the Sost gene, is secreted by osteocytes and inh...
SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone fo...
AbstractMechanical loading is the primary functional determinant of bone mass and architecture, and ...
Osteogenesis imperfecta (OI) is a rare bone disease that is associated with fractures and low bone m...
Mechanical loading is the primary functional determinant of bone mass and architecture, and osteocyt...